5 Most Profitable Pharmaceutical Stocks Now

Page 1 of 5

In this piece, we will take a look at five most profitable pharmaceutical stocks now. For more stocks, head on over to 12 Most Profitable Pharmaceutical Stocks Now.

5. AbbVie Inc. (NYSE:ABBV)

Trailing Twelve Month Net Income: $11.8 billion

Number of Hedge Fund Holders in Q3 2022:

AbbVie Inc. (NYSE:ABBV) is an American pharmaceutical company with treatments for several diseases such as psoriasis, different kinds of cancers, and arthritis, among others. The firm is headquartered in North Chicago, Illinois.

AbbVie Inc. (NYSE:ABBV) had some disappointing news for investors in February 2023 when it announced that sales of its arthritis drug in the U.S. will drop by 37% this year due to competition from cheaper alternatives. 80 of the 920 hedge funds polled by Insider Monkey in Q3 2022 had invested in the company.

AbbVie Inc. (NYSE:ABBV)’s largest investor is Cliff Asness’ AQR Capital Management which owns 1.4 million shares that are worth $228 million.

Follow Abbvie Inc. (NYSE:ABBV)



Page 1 of 5